Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Relationship between pneumonitis induced by immune checkpoint inhibitors and the underlying parenchymal status: a retrospective study.

Pozzessere C, Bouchaab H, Jumeau R, Letovanec I, Daccord C, Bourhis J, Prior JO, Peters S, Lazor R, Beigelman-Aubry C.

ERJ Open Res. 2020 Mar 16;6(1). pii: 00165-2019. doi: 10.1183/23120541.00165-2019. eCollection 2020 Jan.

2.

Combined lung and liver transplantation for short telomere syndrome.

Moschouri E, Vionnet J, Giostra E, Daccord C, Lazor R, Sciarra A, Letovanec I, Sempoux C, Gonzalez M, Unger S, Fodstad H, Haubitz M, Baerlocher GM, Voruz S, Naveiras O, Jacquemin E, Moradpour D, Fraga M.

Liver Transpl. 2020 Feb 20. doi: 10.1002/lt.25734. [Epub ahead of print]

PMID:
32080954
3.

Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease.

Stock CJW, De Lauretis A, Visca D, Daccord C, Kokosi M, Kouranos V, Margaritopoulos G, George PM, Molyneaux PL, Nihtyanova S, Chua F, Maher TM, Ong V, Abraham DJ, Denton CP, Wells AU, Wain LV, Renzoni EA.

Clin Rheumatol. 2020 Jan 8. doi: 10.1007/s10067-019-04922-6. [Epub ahead of print]

PMID:
31916109
4.

Immunotherapy-Induced Airway Disease: A New Pattern of Lung Toxicity of Immune Checkpoint Inhibitors.

Mitropoulou G, Daccord C, Sauty A, Pasche A, Egger B, Aedo Lopez V, Letovanec I, Beigelman-Aubry C, Nicod LP, Lazor R.

Respiration. 2020;99(2):181-186. doi: 10.1159/000504968. Epub 2020 Jan 8.

PMID:
31914436
5.

[Rheumatoid arthritis-associated interstitial lung disease : new genetic data and therapeutic perspectives].

Valerio F, Daccord C, Letovanec I, Hügle T, Lazor R.

Rev Med Suisse. 2019 Mar 6;15(641):536-541. French.

PMID:
30860324
6.

Air travel and incidence of pneumothorax in lymphangioleiomyomatosis.

Gonano C, Pasquier J, Daccord C, Johnson SR, Harari S, Leclerc V, Falconer L, Miano E, Cordier JF, Cottin V, Lazor R.

Orphanet J Rare Dis. 2018 Dec 13;13(1):222. doi: 10.1186/s13023-018-0964-6.

7.

First histopathological evidence of irreversible pulmonary vascular disease in dasatinib-induced pulmonary arterial hypertension.

Daccord C, Letovanec I, Yerly P, Bloch J, Ogna A, Nicod LP, Aubert JD.

Eur Respir J. 2018 Mar 1;51(3). pii: 1701694. doi: 10.1183/13993003.01694-2017. Print 2018 Mar. No abstract available.

8.

Cystic Lung Disease in Genetic Syndromes with Deficient Tumor Suppressor Gene Function.

Daccord C, Nicod LP, Lazor R.

Respiration. 2017;94(6):467-485. doi: 10.1159/000485106. Epub 2017 Nov 23. Review.

9.

Evaluating disease severity in idiopathic pulmonary fibrosis.

Robbie H, Daccord C, Chua F, Devaraj A.

Eur Respir Rev. 2017 Sep 6;26(145). pii: 170051. doi: 10.1183/16000617.0051-2017. Print 2017 Sep 30. Review.

10.

Host-Microbial Interactions in Idiopathic Pulmonary Fibrosis.

Molyneaux PL, Willis-Owen SAG, Cox MJ, James P, Cowman S, Loebinger M, Blanchard A, Edwards LM, Stock C, Daccord C, Renzoni EA, Wells AU, Moffatt MF, Cookson WOC, Maher TM.

Am J Respir Crit Care Med. 2017 Jun 15;195(12):1640-1650. doi: 10.1164/rccm.201607-1408OC.

11.

Recent advances in understanding idiopathic pulmonary fibrosis.

Daccord C, Maher TM.

F1000Res. 2016 May 31;5. pii: F1000 Faculty Rev-1046. doi: 10.12688/f1000research.8209.1. eCollection 2016. Review.

12.
13.

[Lung and pregnancy].

Daccord C, Fitting JW.

Rev Med Suisse. 2013 Nov 20;9(407):2142-4, 2146-9. French.

PMID:
24354248

Supplemental Content

Loading ...
Support Center